Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Radware Rdwr Stock Reacting To Market Price At 27.20 Up 0.67 20260402 Is Archimedes 3 Arci Stock Testing Support Price At 9.90 Up 0.41 20260402 Should I Buy Gct Gcts Stock In 2026 Price At 1.34 Up 11.67 20260406 Is Medical Mpt Stock Good For Portfolio Price At 4.60 Down 0.65 20260406 Is Zoom Communications Zm Stock A Market Leader Price At 82.03 Down 0.40 20260406 When NetScout Systems NTCT Stock Will Fall Institutional Demand 20260418 Avista AVA Stock Why Activist Investor Investor Concern 20260418 How Maiden MHNC thinks about risk management MHNC Q3 Earnings Maiden Special Notes Report No Data Visa V Stock Upside Potential Momentum Fading 20260416 MicroCloud Hologram HOLO Stock Breakout Trade Investor Concern 20260420 What is the sentiment on Virtus NIE stock today NIE Latest Quarter Earnings Virtus reports no EPS revenue metrics amid market pressure IMNM Immunome posts wider than expected Q4 2025 loss shares rise as investors look past earnings miss MarineMax HZO Q1 earnings fall short of estimates by 18 percent stock drops 184 percent today Playtika Holding PLTK Stock Buy Decision Breakdown Playtika Holding posts 694 negative EPS surprise HLNE Hamilton delivers 145 percent Q1 2026 EPS beat but stock edges down 156 percent in todays session Powell Industries POWL Stock Technical Analysis Q1 2026 EPS Beats Forecasts NIO Inc NIO Expands Strategic Partnership with onsemi to Accelerate NextGeneration 900V EV Platform Rollout What Federal FRT is doing that creates lasting advantage FRT Q1 2026 Earnings Federal posts 155 EPS blowout topping Street view Vanguard Real Estate ETF VNQ Top Dividend Income Picks for 2026 Trump Invites Elon Musk Tim Cook Larry Fink and Other Top CEOs to Join China Trip for Xi Summit Jim Cramer Advises Caution on Wynn Resorts I Gotta Hold Off for Now Dell Tech DELL Reports Strong Q1 2026 Revenue NA EPS Beats Iran Conflict Disrupts Los Angeles Housing Market Path to Recovery Remains Uncertain BoundlessBio BOLD Q1 2026 Results Miss Estimates EPS 060 vs 059 Indonesias Financial Sector Urged to Prioritize Resilience Over Expansion Angel Oak 29 AOMN Stalls at 2510 Breakout or Breakdown 20260518 Infleqtion INFQ Drops 860 Key Support at 1080 20260518 1RT ONCHW Notches 220 Gain Bulls Tighten Grip 20260521 Rupee Slips to Record Low Near 97 Per Dollar Amid Oil Price Pressures and US Treasury Yield Spike Supermarkets Resist Government Pressure for Price Caps on Milk Bread and Eggs Minister Rules Out Mandatory Measures Cerebras IPO Surges as Investors Bet on AI Chip Disruptor at a Fraction of Nvidia and AMDs Combined Market Value Standard Chartered to Slash Corporate Roles by Over 15 in Efficiency Drive Evercore ISI Lowers Price Target on Illinois Tool Works ITW Amid Revised Outlook Japans Nikkei 225 Surpasses 64000 for First Time as Oil Prices Slide on Hormuz Reopening Hopes Fed Rate Hike Odds Surge as Hot Inflation Data Reshapes Market Expectations CTKB Q1 2026 Earnings EPS Misses Estimates as Operating Losses Widen TechPrecision Corporation TPCS Q1 2026 Earnings Narrowing Losses Amid Strategic Restructuring NPK Q3 2023 Earnings Earnings per Share of 099 Highlights Modest Quarter GTES Q1 2026 Earnings EPS Surpasses Estimates by 47 Velocity Financial Q1 2026 Earnings EPS Beat Amid Modest Stock Pressure Flanigans Enterprises BDL Bounces Higher Support Holds Amid Modest Gains Fractyl Health GUTS Holds Near Support After Minor Decline CF Financial Corporation CFFI Faces Modest Pullback Support and Resistance Levels in Focus Oil States OIS Stock Price to Sales Smart Money Exits 20260418 Medicus Pharma MDCX Stock Is It a Strong Investment Pick 1700 20260418 STMicroelectronics NV STM Stock Market Sentiment 054 20260415 Is SkyWest SKYW stock outperforming the market SkyWest Inc beats EPS estimates by 14 percent RCON Recon Technology Ltd posts far narrower Q4 2025 loss than estimates shares rise 225 percent in todays trading Warner WBD Industry Headwinds Q4 2025 Below Expectations OVID Ovid Therapeutics Inc far exceeds Q4 2025 EPS expectations shares rise nearly four percent